دورية أكاديمية

P1388: EFFECTIVENESS AND SAFETY OUTCOMES IN PATIENTS WITH EBV+ PTLD TREATED WITH ALLOGENEIC EBV-SPECIFIC T-CELL IMMUNOTHERAPY (TABELECLEUCEL) UNDER AN EXPANDED ACCESS PROGRAM IN EUROPE

التفاصيل البيبلوغرافية
العنوان: P1388: EFFECTIVENESS AND SAFETY OUTCOMES IN PATIENTS WITH EBV+ PTLD TREATED WITH ALLOGENEIC EBV-SPECIFIC T-CELL IMMUNOTHERAPY (TABELECLEUCEL) UNDER AN EXPANDED ACCESS PROGRAM IN EUROPE
المؤلفون: Choquet, Sylvain, Clark, Andrew, Renard, Cécile, Uttenthal, Ben, Chaganti, Sridhar, Ulrich Trappe, Ralf, Comoli, Patrizia, Duan, Xinyuan, Xing, Baodong, Wu, Charley, Gamelin, Laurence, Terwey, Jan-Henrik, Friedetzky, Anke, Dierickx, Daan
المصدر: HemaSphere ; volume 7, issue S3, page e8073255 ; ISSN 2572-9241
بيانات النشر: Wiley
سنة النشر: 2023
المجموعة: Wiley Online Library (Open Access Articles via Crossref)
نوع الوثيقة: article in journal/newspaper
اللغة: English
DOI: 10.1097/01.hs9.0000972440.80732.55
DOI: 10.1097/01.HS9.0000972440.80732.55
الإتاحة: https://doi.org/10.1097/01.hs9.0000972440.80732.55Test
حقوق: http://creativecommons.org/licenses/by-nc-nd/4.0Test/
رقم الانضمام: edsbas.47190135
قاعدة البيانات: BASE